Business Description
Khiron Life Sciences Corp
NAICS : 325410
SIC : 3741
ISIN : CA49374L3065
Compare
Compare
Traded in other countries / regions
KHRNF.USAKHRN.H.Canada4KH.Germany IPO Date
2018-10-05Description
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -110.07 | |||||
OCF Margin % | -92.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.51 | |||||
EV-to-Forward-Revenue | 0.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Khiron Life Sciences Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 11.712 | ||
| EPS (TTM) (€) | -0.12 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -35.58 | ||
| 3-Year Sortino Ratio | -3.45 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 0.0216 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.0216 - 0.0216 | ||
| Shares Outstanding (Mil) | 232.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Khiron Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Khiron Life Sciences Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Khiron Life Sciences Corp Frequently Asked Questions
What is Khiron Life Sciences Corp(STU:4KH)'s stock price today?
The current price of STU:4KH is €0.02. The 52 week high of STU:4KH is €0.02 and 52 week low is €0.02.
When is next earnings date of Khiron Life Sciences Corp(STU:4KH)?
The next earnings date of Khiron Life Sciences Corp(STU:4KH) is .
Does Khiron Life Sciences Corp(STU:4KH) pay dividends? If so, how much?
Khiron Life Sciences Corp(STU:4KH) does not pay dividend.
Press Release
Articles on Khiron Life Sciences Corp
No articles.